global pharmaceutical company
safely test early-stage HCP communication
AI-generated personas
speed, compliance and actionable insights
Launching a new medication involves more than regulatory approval. It demands clear, compelling, and compliant communication with healthcare professionals (HCPs)—especially when the treatment is novel or addresses unmet medical needs.
One of DataDiggers' global pharma clients faced this exact challenge while developing messaging for an upcoming treatment in the oncology space. The team needed to test multiple versions of their HCP communication in the early creative stage, before committing budget to live testing.
However, they were constrained by:
The brand team needed a safe, fast, and insightful way to evaluate how their messaging might be received by target HCP audiences—without yet involving actual HCPs.
Enter Syntheo—DataDiggers’ AI-driven solution for generating synthetic insights through realistic digital personas.
Syntheo builds credible, deeply profiled synthetic respondents based on extensive historical and contextual data. For this case, Syntheo simulated board-certified oncologists, radiologists, and hospital pharmacists from three priority markets: Germany, Japan, and the United States.
These AI personas reflected nuanced professional and cultural realities, including:
Crucially, all responses were synthetic—meaning the client could test sensitive communication materials in a 100% privacy-safe environment, free of GDPR or HIPAA exposure.
DataDiggers worked with the client’s brand and medical affairs teams to:
The Syntheo dashboard presented findings in real-time through smart heatmaps, sentiment analysis, and decision-mapping overlays—allowing the team to instantly understand which messages resonated and why.
Within 48 hours, the client received deep, multi-market feedback that previously would have taken 4–6 weeks and significant budget.
Key outcomes included:
Most importantly, the team avoided any premature data sharing with real HCPs—keeping them fully compliant and minimizing reputational risk.
This case illustrates the power of synthetic insights when speed, safety, and precision matter most. Syntheo helped our client:
In an industry where timelines are tight and standards are high, DataDiggers provides a future-proof solution for early testing—without cutting corners.
Whether you're designing HCP messaging, testing patient materials, or simulating clinical trial engagement, Syntheo and Modeliq can help you move faster, safer, and smarter.
Contact us to learn more
Explore how synthetic personas choose survey answers
Learn about our compliance and data integrity standards
DataDiggers is a global, technology-powered market research agency founded in 2015. We combine deep panel expertise with AI-driven innovation to deliver fast, high-quality insights for brands and agencies worldwide. Through our proprietary platforms—Brainactive, Syntheo, Modeliq, and Correlix—we help organizations test, model, and validate decisions with confidence.